The epithelial-mesenchymal transition (EMT) regulatory factor SLUG (SNAI2) is a downstream target of SPARC and AKT in promoting melanoma cell invasion
about
P-cadherin and the journey to cancer metastasisPhosphatase and tensin homolog deleted on chromosome 10 (PTEN) and PH domain and leucine-rich repeat phosphatase cross-talk (PHLPP) in cancer cells and in transforming growth factor β-activated stem cellsAurora kinases: novel therapy targets in cancersPhenotype switching in melanoma: implications for progression and therapy.Triclosan potentiates epithelial-to-mesenchymal transition in anoikis-resistant human lung cancer cellsRestoration of the anti-proliferative and anti-migratory effects of 1,25-dihydroxyvitamin D by silibinin in vitamin D-resistant colon cancer cells.SPARC Controls Melanoma Cell Plasticity through Rac1.Fibrillin-1, induced by Aurora-A but inhibited by BRCA2, promotes ovarian cancer metastasisInhibition of Snail Family Transcriptional Repressor 2 (SNAI2) Enhances Multidrug Resistance of Hepatocellular Carcinoma CellsA Novel Nanoprobe for Multimodal Imaging Is Effectively Incorporated into Human Melanoma Metastatic Cell Lines.A peptide that inhibits function of Myristoylated Alanine-Rich C Kinase Substrate (MARCKS) reduces lung cancer metastasis.Sulforaphane inhibits thyroid cancer cell growth and invasiveness through the reactive oxygen species-dependent pathway.miR-203 Functions as a Tumor Suppressor by Inhibiting Epithelial to Mesenchymal Transition in Ovarian CancerBasal/HER2 breast carcinomas: integrating molecular taxonomy with cancer stem cell dynamics to predict primary resistance to trastuzumab (Herceptin).Fisetin, a dietary flavonoid, augments the anti-invasive and anti-metastatic potential of sorafenib in melanoma.PTTG promotes invasion in human breast cancer cell line by upregulating EMMPRIN via FAK/Akt/mTOR signalingSlug inhibits the proliferation and tumor formation of human cervical cancer cells by up-regulating the p21/p27 proteins and down-regulating the activity of the Wnt/β-catenin signaling pathway via the trans-suppression Akt1/p-Akt1 expression.Targeting ROR1 inhibits epithelial-mesenchymal transition and metastasis.Fluid shear stress induces epithelial-mesenchymal transition (EMT) in Hep-2 cells.TrkC promotes survival and growth of leukemia cells through Akt-mTOR-dependent up-regulation of PLK-1 and Twist-1.Notch4 Signaling Induces a Mesenchymal-Epithelial-like Transition in Melanoma Cells to Suppress Malignant Behaviors.FKBP51 increases the tumour-promoter potential of TGF-beta.Melanoma stem cells and metastasis: mimicking hematopoietic cell trafficking?Cadherin-6 type 2, K-cadherin (CDH6) is regulated by mutant p53 in the fallopian tube but is not expressed in the ovarian surface.In vivo animal models for studying brain metastasis: value and limitations.Molecular and cellular pathogenesis of melanoma initiation and progression.Molecular networks in melanoma invasion and metastasis.Transforming growth factor-Beta and urokinase-type plasminogen activator: dangerous partners in tumorigenesis-implications in skin cancer.The therapeutic potential of targeting the epithelial-mesenchymal transition in cancer.Gambogenic acid induces cell growth inhibition, cell cycle arrest and metastasis inhibition in choroidal melanoma in a dose-dependent manner.Comparative oncogenomics identifies tyrosine kinase FES as a tumor suppressor in melanoma.Effect of Adipocyte Secretome in Melanoma Progression and Vasculogenic Mimicry.Moscatilin inhibits epithelial-to-mesenchymal transition and sensitizes anoikis in human lung cancer H460 cells.RhoB loss induces Rac1-dependent mesenchymal cell invasion in lung cells through PP2A inhibition.Tumour-derived SPARC drives vascular permeability and extravasation through endothelial VCAM1 signalling to promote metastasis.PI3K signalling is required for a TGFβ-induced epithelial-mesenchymal-like transition (EMT-like) in human melanoma cells.Der p 2 promotes motility of airway epithelial cell attributing to AKT/GSK3β-associated epithelial-to-mesenchymal transition.Ribonucleotide reductase M2B inhibits cell migration and spreading by early growth response protein 1-mediated phosphatase and tensin homolog/Akt1 pathway in hepatocellular carcinoma.Potential therapeutic targets of epithelial-mesenchymal transition in melanoma.Silencing endothelin-3 expression attenuates the malignant behaviors of human melanoma cells by regulating SPARC levels.
P2860
Q26781906-2568BF26-0F68-4CDC-91D7-53DE2E3CB428Q28384799-93F1A95C-C877-42EC-A4AC-4D19237E3DA9Q33618929-92025829-8133-46E9-8A20-A023D089F485Q35081779-357C8717-93E3-48AC-862C-1B4F4228FE49Q35347566-F5242222-FE13-4D21-AE16-D90B9FB38C55Q35568534-D1AC034D-4CA9-4960-808C-8234EEEC44ECQ35738973-0C01D5B7-9A73-4302-A67C-3CA264C51274Q35740047-462F26FA-B54E-42C5-AA5B-2136D8AB13DEQ36167817-065851C0-8913-492F-8746-C014A9FBE1C0Q36184142-83E1ED24-DE6C-4306-8A08-7C4FCC16B615Q36244135-A9467FD0-8277-45E6-A2D9-B0213322C2F2Q36413327-973C9116-1723-47DB-9BCA-0BC692A875E3Q36497625-BE66F340-9E80-4C33-9568-ABB68CD991F7Q36618624-E12660C9-E196-4FF8-B457-B0738C7D224FQ36738788-DF4B293B-F6AC-492B-93C7-E49CD52CF953Q36878749-D5395C94-2C60-442C-89A0-C24144E35875Q37295608-AB2B62BE-518D-40BD-BEA7-BC1CD62B1F8AQ37320359-1B0F46ED-EC2E-4DEC-B356-E0F14965222BQ37362793-F7B39729-F3AE-44B2-B66F-19D96BE8CF4BQ37462530-90FE3874-F3D4-476D-8E9F-4F84282EACEAQ37515480-E46605CB-4737-44E0-8741-EAD535069C67Q37531822-9EB3F404-4ACF-471E-AFDA-E02DCCF1E964Q37615286-174C5305-C1DF-4842-8267-4C09C321B84BQ37688456-9F550617-587E-49CF-8912-D67659B4F2DFQ38074351-29083D0A-E5F7-4EED-8328-D8E54367A521Q38093446-84DB7E04-3818-45CB-B4F6-548D22942445Q38104416-0F418201-A6DA-45FD-A5FF-ACA9BABB8A47Q38132176-8BA0FE53-D395-4EAA-9426-7D39E5EF8037Q38206587-7BDC7EB6-B5B7-4C03-B1BF-95BFE939D13AQ38701719-3F22C204-41AB-4C8C-A0A9-64C7DC93F70AQ38809327-39B6CEDC-067C-4CFC-9A90-913863E57A75Q38811845-B4DD270A-EACC-444F-AD34-0218B3C7A061Q38834297-9A8ACCB1-8BB0-4E67-9083-6C7B09F55B72Q38856262-19AB21F9-5109-4306-95DD-6B508F1A9CC7Q38880787-B77BBF04-0758-41A6-BDC7-DAB26A16CBFEQ38943325-F35DC4CF-B8CE-4F71-9CA2-DF9A56EFD6A9Q38984232-ABD5DCBC-434F-433A-B2CC-2258C4A56CE3Q39064797-84B64828-02C6-4266-9BA6-2EA0F65051B0Q39107981-4430F269-7E57-4075-A33E-A9162CC23B59Q39117240-22020CA7-BD7C-4721-A3F5-4A0476F371EC
P2860
The epithelial-mesenchymal transition (EMT) regulatory factor SLUG (SNAI2) is a downstream target of SPARC and AKT in promoting melanoma cell invasion
description
2012 nî lūn-bûn
@nan
2012 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
The epithelial-mesenchymal tra ...... omoting melanoma cell invasion
@ast
The epithelial-mesenchymal tra ...... omoting melanoma cell invasion
@en
The epithelial-mesenchymal transition
@nl
type
label
The epithelial-mesenchymal tra ...... omoting melanoma cell invasion
@ast
The epithelial-mesenchymal tra ...... omoting melanoma cell invasion
@en
The epithelial-mesenchymal transition
@nl
prefLabel
The epithelial-mesenchymal tra ...... omoting melanoma cell invasion
@ast
The epithelial-mesenchymal tra ...... omoting melanoma cell invasion
@en
The epithelial-mesenchymal transition
@nl
P2093
P2860
P50
P1433
P1476
The epithelial-mesenchymal tra ...... omoting melanoma cell invasion
@en
P2093
Amir Khammari
Anaïs Pottier
Ariane Mogha
Aude Mallavialle
Jean-Philippe Lacour
Julia K Soo
Maeva Dufies
Marcel Deckert
Marie-Dominique Galibert
Nina Fenouille
P2860
P304
P356
10.1371/JOURNAL.PONE.0040378
P407
P577
2012-07-20T00:00:00Z